THE European Commission announced today it has concluded exploratory talks with Franco-Austrian biotechnology laboratory Valneva for the possible purchase of up to 60 million doses of its Covid-19 vaccine.
The EU executive has already signed contracts with six other laboratories and is also in discussions with US firm Novavax to secure 200 million doses.